相似文献
1
[Various therapy options. Medical Chemistry of platelet aggregation inhibitors].
Pharm Unserer Zeit. 2009;38(4):314-9. doi: 10.1002/pauz.200900320.
2
[The anti-platelet aggregation drugs: new approaches based on snake venom polypeptides].
Arch Inst Pasteur Tunis. 1997 Jan-Apr;74(1-2):9-15.
3
[Pharmazie in unserer Zeit 4/2009].
Pharm Unserer Zeit. 2009;38(4):295. doi: 10.1002/pauz.200990042.
4
[Antagonists of platelet P2 receptors: achievements, problems, and prospects].
Eksp Klin Farmakol. 2010 Apr;73(4):38-43.
5
Pharmacological approaches to studying platelet function: an overview.
Methods Mol Biol. 2004;273:73-86. doi: 10.1385/1-59259-783-1:073.
6
Antiplatelet drugs.
Br J Pharmacol. 2006 Jan;147 Suppl 1(Suppl 1):S241-51. doi: 10.1038/sj.bjp.0706401.
7
Platelet-active drugs : the relationships among dose, effectiveness, and side effects.
Chest. 2001 Jan;119(1 Suppl):39S-63S. doi: 10.1378/chest.119.1_suppl.39s.
8
Platelet function testing and implications for clinical practice.
J Cardiovasc Pharmacol Ther. 2009 Sep;14(3):157-69. doi: 10.1177/1074248409339309.
9
Preoperative stop or continue? New antithrombotic and anticoagulants.
Acta Anaesthesiol Belg. 2001;52(4):385-93.
10
Pharmacological control of platelet function.
Pharmacol Res. 2001 Oct;44(4):255-64. doi: 10.1006/phrs.2001.0861.
Zotero 插件